LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk

Although papillary thyroid carcinoma (PTC) has a good prognosis, 20–90% of patients show metastasis to regional lymph nodes and 10–15% of patients show metastasis to distant sites. Metastatic disease represents the main clinical challenge that impacts survival rate. We previously showed that LIMD2 w...

Full description

Bibliographic Details
Main Authors: Rodrigo Pinheiro Araldi, Thatiana Correa de Melo, Débora Levy, Dener Madeiro de Souza, Beatriz Maurício, Gabriel Avelar Colozza-Gama, Sergio Paulo Bydlowski, Hongzhuang Peng, Frank J. Rauscher, Janete Maria Cerutti
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2522
_version_ 1827701706550411264
author Rodrigo Pinheiro Araldi
Thatiana Correa de Melo
Débora Levy
Dener Madeiro de Souza
Beatriz Maurício
Gabriel Avelar Colozza-Gama
Sergio Paulo Bydlowski
Hongzhuang Peng
Frank J. Rauscher
Janete Maria Cerutti
author_facet Rodrigo Pinheiro Araldi
Thatiana Correa de Melo
Débora Levy
Dener Madeiro de Souza
Beatriz Maurício
Gabriel Avelar Colozza-Gama
Sergio Paulo Bydlowski
Hongzhuang Peng
Frank J. Rauscher
Janete Maria Cerutti
author_sort Rodrigo Pinheiro Araldi
collection DOAJ
description Although papillary thyroid carcinoma (PTC) has a good prognosis, 20–90% of patients show metastasis to regional lymph nodes and 10–15% of patients show metastasis to distant sites. Metastatic disease represents the main clinical challenge that impacts survival rate. We previously showed that LIMD2 was a novel metastasis-associated gene. In this study, to interrogate the role of LIMD2 in cancer invasion and metastasis, we used CRISPR-mediated knockout (KO) of LIMD2 in PTC cells (BCPAP and TPC1). Western blot and high-content screening (HCS) analysis confirmed functional KO of LIMD2. LIMD2 KO reduced in vitro invasion and migration. Ultrastructural analyses showed that cell polarity and mitochondria function and morphology were restored in LIMD2 KO cells. To unveil the signals supervising these phenotypic changes, we employed phospho-protein array. Several members of the MAPK superfamily showed robust reduction in phosphorylation. A Venn diagram displayed the overlap of kinases with reduced phosphorylation in both cell lines and showed that they were able to initiate or sustain the epithelial-mesenchymal transition (EMT) and DNA damage checkpoint. Flow cytometry and HCS validation analyses further corroborated the phospho-protein array data. Collectively, our findings show that LIMD2 enhances phosphorylation of kinases associated with EMT and invasion. Through cooperation with different kinases, it contributes to the increased genomic instability that ultimately promotes PTC progression.
first_indexed 2024-03-10T14:39:09Z
format Article
id doaj.art-a2d37603262541e6a54de04780fa2753
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T14:39:09Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-a2d37603262541e6a54de04780fa27532023-11-20T21:56:26ZengMDPI AGCells2073-44092020-11-01911252210.3390/cells9112522LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK CrosstalkRodrigo Pinheiro Araldi0Thatiana Correa de Melo1Débora Levy2Dener Madeiro de Souza3Beatriz Maurício4Gabriel Avelar Colozza-Gama5Sergio Paulo Bydlowski6Hongzhuang Peng7Frank J. Rauscher8Janete Maria Cerutti9Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo/EPM, São Paulo, SP 04039-032, BrazilPrograma de Pós-graduação em Biociências, Universidade Federal da Integração Latino-Americana (UNILA), Foz do Iguaçu, PR 85866-000, BrazilLaboratory of Histocompatibility and Cellular Immunity, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP 05404-000, BrazilGenetics Laboratory, Instituto Butantan, São Paulo, SP 05503-900, BrazilLaboratory of Cell Biology, Instituto Butantan, São Paulo, SP 05503-900, BrazilGenetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo/EPM, São Paulo, SP 04039-032, BrazilLaboratory of Histocompatibility and Cellular Immunity, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP 05404-000, BrazilThe Wistar Institute, Philadelphia, PA 19104, USAThe Wistar Institute, Philadelphia, PA 19104, USAGenetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo/EPM, São Paulo, SP 04039-032, BrazilAlthough papillary thyroid carcinoma (PTC) has a good prognosis, 20–90% of patients show metastasis to regional lymph nodes and 10–15% of patients show metastasis to distant sites. Metastatic disease represents the main clinical challenge that impacts survival rate. We previously showed that LIMD2 was a novel metastasis-associated gene. In this study, to interrogate the role of LIMD2 in cancer invasion and metastasis, we used CRISPR-mediated knockout (KO) of LIMD2 in PTC cells (BCPAP and TPC1). Western blot and high-content screening (HCS) analysis confirmed functional KO of LIMD2. LIMD2 KO reduced in vitro invasion and migration. Ultrastructural analyses showed that cell polarity and mitochondria function and morphology were restored in LIMD2 KO cells. To unveil the signals supervising these phenotypic changes, we employed phospho-protein array. Several members of the MAPK superfamily showed robust reduction in phosphorylation. A Venn diagram displayed the overlap of kinases with reduced phosphorylation in both cell lines and showed that they were able to initiate or sustain the epithelial-mesenchymal transition (EMT) and DNA damage checkpoint. Flow cytometry and HCS validation analyses further corroborated the phospho-protein array data. Collectively, our findings show that LIMD2 enhances phosphorylation of kinases associated with EMT and invasion. Through cooperation with different kinases, it contributes to the increased genomic instability that ultimately promotes PTC progression.https://www.mdpi.com/2073-4409/9/11/2522papillary thyroid carcinomaLIMD2BRAF V600ECRISPR/Cas9epithelial-to-mesenchymal transition
spellingShingle Rodrigo Pinheiro Araldi
Thatiana Correa de Melo
Débora Levy
Dener Madeiro de Souza
Beatriz Maurício
Gabriel Avelar Colozza-Gama
Sergio Paulo Bydlowski
Hongzhuang Peng
Frank J. Rauscher
Janete Maria Cerutti
LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
Cells
papillary thyroid carcinoma
LIMD2
BRAF V600E
CRISPR/Cas9
epithelial-to-mesenchymal transition
title LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
title_full LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
title_fullStr LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
title_full_unstemmed LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
title_short LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk
title_sort limd2 regulates key steps of metastasis cascade in papillary thyroid cancer cells via mapk crosstalk
topic papillary thyroid carcinoma
LIMD2
BRAF V600E
CRISPR/Cas9
epithelial-to-mesenchymal transition
url https://www.mdpi.com/2073-4409/9/11/2522
work_keys_str_mv AT rodrigopinheiroaraldi limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT thatianacorreademelo limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT deboralevy limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT denermadeirodesouza limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT beatrizmauricio limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT gabrielavelarcolozzagama limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT sergiopaulobydlowski limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT hongzhuangpeng limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT frankjrauscher limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk
AT janetemariacerutti limd2regulateskeystepsofmetastasiscascadeinpapillarythyroidcancercellsviamapkcrosstalk